Literature DB >> 6848724

Preliminary results on the mental development of hypothyroid infants detected by the Quebec Screening Program.

J Glorieux, J H Dussault, J Letarte, H Guyda, J Morissette.   

Abstract

A prospective study of the mental development of hypothyroid infants detected by the Quebec Network for Genetic Medicine began in January, 1976. The mean age at initiation of thyroid hormone therapy was 27 days. Forty-five hypothyroid infants and 37 normal control subjects were assessed at age 12 months with the Griffiths mental development test; 77 and 41, respectively, were assessed at age 18 months, and 59 and 40, respectively, at 36 months. There were no statistically significant differences in the various test scores between the two populations at age 12 months, but at age 18 and 36 months the hypothyroid infants had lower scores in hearing-speech performance scales and practical reasoning (36 months) which also decreased their global quotient. The mean scores were still above 100 and only nine were below 85. Further assessment of the influence of early therapy on mental development at age 6 years is needed before definitive statements can be made about the long-term mental development in these subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848724     DOI: 10.1016/s0022-3476(83)80279-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

Review 1.  Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.

Authors:  W Zheng
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

2.  Inhibition by lead of production and secretion of transthyretin in the choroid plexus: its relation to thyroxine transport at blood-CSF barrier.

Authors:  W Zheng; W S Blaner; Q Zhao
Journal:  Toxicol Appl Pharmacol       Date:  1999-02-15       Impact factor: 4.219

Review 3.  Periodic health examination, 1990 update: 1. Early detection of hyperthyroidism and hypothyroidism in adults and screening of newborns for congenital hypothyroidism. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1990-05-01       Impact factor: 8.262

4.  Early treated hypothyroidism: development at 3 years.

Authors:  G Murphy; J A Hulse; D Jackson; P Tyrer; J Glossop; I Smith; D Grant
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

5.  Neonatal screening for congenital hypothyroidism in a developing country: problems and strategies.

Authors:  M P Desai; M P Colaco; A R Ajgaonkar; C V Mahadik; F E Vas; C Rege; V V Shirodkar; A Bandivdekar; A R Sheth
Journal:  Indian J Pediatr       Date:  1987 Jul-Aug       Impact factor: 1.967

6.  Management of congenital hypothyroidism.

Authors:  S J Clark
Journal:  West J Med       Date:  1984-06

7.  Screening for congenital hypothyroidism: the first decade.

Authors:  N D Barnes
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

8.  Transthyretin, thyroxine, and retinol-binding protein in human cerebrospinal fluid: effect of lead exposure.

Authors:  W Zheng; Y M Lu; G Y Lu; Q Zhao; O Cheung; W S Blaner
Journal:  Toxicol Sci       Date:  2001-05       Impact factor: 4.849

9.  Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect.

Authors:  S L Tillotson; P W Fuggle; I Smith; A E Ades; D B Grant
Journal:  BMJ       Date:  1994-08-13

10.  Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism.

Authors:  S S Abusrewil; L Tyfield; D C Savage
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.